| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
19,183 |
17,240 |
$1.62M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
10,692 |
9,245 |
$671K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,799 |
3,536 |
$335K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,306 |
1,151 |
$211K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,845 |
1,506 |
$184K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,358 |
1,623 |
$141K |
| 80053 |
Comprehensive metabolic panel |
9,346 |
7,484 |
$104K |
| G0378 |
Hospital observation service, per hour |
1,275 |
600 |
$89K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
786 |
751 |
$82K |
| 87070 |
|
2,214 |
2,006 |
$67K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
514 |
471 |
$47K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
746 |
686 |
$46K |
| 84703 |
|
4,350 |
3,985 |
$45K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,475 |
3,795 |
$41K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
433 |
389 |
$35K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,497 |
1,780 |
$28K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,664 |
4,058 |
$27K |
| J3490 |
Unclassified drugs |
799 |
587 |
$24K |
| 71045 |
Radiologic examination, chest; single view |
5,198 |
4,403 |
$22K |
| 71046 |
Radiologic examination, chest; 2 views |
1,535 |
1,362 |
$20K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,673 |
4,847 |
$19K |
| 81001 |
|
5,611 |
4,922 |
$15K |
| 85027 |
|
12,123 |
8,984 |
$14K |
| 81003 |
|
2,866 |
2,510 |
$13K |
| A9270 |
Non-covered item or service |
4,224 |
1,015 |
$13K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
509 |
152 |
$12K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
205 |
167 |
$12K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
175 |
134 |
$11K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,350 |
1,155 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,692 |
3,731 |
$8K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
645 |
549 |
$8K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,189 |
3,404 |
$7K |
| 84484 |
|
3,003 |
1,897 |
$6K |
| 74018 |
|
304 |
283 |
$6K |
| 85610 |
|
2,283 |
1,834 |
$6K |
| 36415 |
Collection of venous blood by venipuncture |
940 |
678 |
$5K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,593 |
2,772 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,101 |
919 |
$5K |
| 85730 |
|
1,941 |
1,583 |
$4K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,617 |
2,063 |
$4K |
| 83735 |
|
2,202 |
1,679 |
$4K |
| 83690 |
|
1,992 |
1,696 |
$4K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
108 |
99 |
$4K |
| 73610 |
|
84 |
76 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,402 |
4,045 |
$3K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
43 |
39 |
$3K |
| 87430 |
|
1,885 |
1,804 |
$3K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
226 |
144 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
273 |
207 |
$3K |
| J2704 |
Injection, propofol, 10 mg |
167 |
123 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
741 |
602 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,032 |
776 |
$2K |
| 87077 |
|
223 |
189 |
$2K |
| 87205 |
|
142 |
101 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,076 |
889 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
284 |
193 |
$2K |
| 87040 |
|
964 |
623 |
$2K |
| 84702 |
|
80 |
76 |
$2K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
928 |
864 |
$2K |
| 82550 |
|
793 |
656 |
$2K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
136 |
100 |
$2K |
| 73630 |
|
70 |
69 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,778 |
2,336 |
$1K |
| 83880 |
|
1,167 |
840 |
$1K |
| 85378 |
|
384 |
312 |
$1K |
| 80061 |
Lipid panel |
307 |
237 |
$1K |
| 86850 |
|
54 |
39 |
$1K |
| 82150 |
|
324 |
280 |
$1K |
| 73620 |
|
12 |
12 |
$918.23 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
40 |
24 |
$895.68 |
| 82553 |
|
30 |
17 |
$772.91 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,452 |
1,198 |
$720.37 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,445 |
1,213 |
$686.18 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
12 |
12 |
$652.87 |
| 73130 |
|
25 |
24 |
$569.17 |
| 87807 |
|
616 |
599 |
$508.22 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
110 |
79 |
$500.00 |
| 83605 |
|
609 |
482 |
$492.67 |
| 86900 |
|
167 |
145 |
$451.30 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
13 |
12 |
$395.34 |
| 73030 |
|
15 |
14 |
$344.41 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
124 |
84 |
$243.10 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
161 |
116 |
$242.94 |
| 82948 |
|
47 |
33 |
$229.04 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
600 |
423 |
$187.08 |
| 80076 |
|
54 |
47 |
$154.63 |
| 97597 |
|
29 |
13 |
$125.80 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
1,179 |
984 |
$92.38 |
| J2060 |
Injection, lorazepam, 2 mg |
249 |
202 |
$50.00 |
| 86901 |
|
153 |
131 |
$30.33 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
272 |
244 |
$24.21 |
| 80320 |
|
81 |
74 |
$13.24 |
| 84100 |
|
13 |
12 |
$3.54 |
| 87081 |
|
15 |
12 |
$0.00 |
| 82077 |
|
195 |
171 |
$0.00 |
| 86140 |
|
16 |
13 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
79 |
46 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
43 |
42 |
$0.00 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
53 |
40 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
12 |
12 |
$0.00 |